

COVID-19 Rapid Diagnostic Test Kit Market Scope:
Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
The COVID-19 Rapid Diagnostic Test Kit market research reports indicate a growing demand for rapid testing solutions in response to the pandemic. The market size is projected to reach $4.3 billion by 2025, driven by increased testing requirements in healthcare settings, airports, and workplaces. Rapid test kits offer quick results and help in controlling the spread of the virus.
Request Sample Report
Companies Covered (Covid 19 Impact Covered)
◍ RayBiotech Life
◍ Aurora Biomed
◍ SD Biosensor
◍ INSTI
◍ CTK Biotech
◍ SBL Testing Technologies
◍ Biopanda
◍ Roche Diagnostics
◍ JOYSBIO
◍ Abingdon Health
◍ TestLine Clinical Diagnostics
◍ Assay Genie
◍ Nadal-test
◍ Panodyne
◍ Luminex
◍ Abbott
◍ AESKU.GROUP
The competitive landscape of COVID-19 Rapid Diagnostic Test Kit Market includes companies such as Roche Diagnostics, Abbott, Quidel, BGI, and Luminex. These companies provide innovative testing solutions to help combat the spread of COVID-19 and contribute to the growth of the market.
- Roche Diagnostics: Sales revenue of $14.96 billion
- Abbott: Sales revenue of $10.19 billion
- Quidel: Sales revenue of $1.12 billion
- BGI: Sales revenue of $2.04 billion
◍ Hospital
◍ Company
◍ School
◍ Home
◍ Others
◍ Antibody Rapid Test Kit
◍ Antigen Rapid Test Kit
Request Sample Report